Uvence, a company set up by cosmetic surgeon Dr Olivier Amar and Reece Tomlinson, plans to disrupt the non-surgical cosmetic treatment market with a new skin rejuvenation treatment.

The procedure provides an on-demand cosmetic treatment tool to cosmetic doctors and clinics across the UK.

Uvence says it is backed by a suite of private investors from the UK, France, Monaco, Greece, the Middle East and Canada. Uvence is currently preparing for a raise next month.

Amar said: “The Uvence offering allows access to regenerative and personalised treatments and is the biggest advance in the field for nearly 15 years. In terms of accessibility and convenience this has never been seen before, the cryopreservation capability allows plastic and cosmetic surgeons alike to provide this treatment on a consistent basis to their patients without the need for further liposuction or tissue extraction.”

Date published: August 13, 2020

Continue reading

Subscribe to get unlimited digital access.


Already a subscriber? Login